文献速递皮肤肿瘤

1990至2017年33个国家角质形成细胞皮肤癌发病率、死亡率及疾病负担趋势

Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017.
PubMed 文献 · Br J Dermatol · 2023-01-01

该观察性研究基于全球疾病负担数据库,分析1990至2017年33个高收入国家角质形成细胞皮肤癌(基底细胞癌和皮肤鳞状细胞癌)的年龄标化发病率、皮肤鳞状细胞癌死亡率和伤残调整寿命年趋势。结果显示,2015至2017年基底细胞癌和皮肤鳞状细胞癌年龄标化发病率最高的国家均为美国和澳大利亚;皮肤鳞状细胞癌死亡率在多数国家呈下降趋势,33个国家中男性24个、女性25个国家的皮肤鳞状细胞癌伤残调整寿命年总体减少。

要点

  • 2015至2017年基底细胞癌和皮肤鳞状细胞癌年龄标化发病率最高的国家均为美国和澳大利亚。
  • 观察期内皮肤鳞状细胞癌死亡率呈下降趋势的国家数多于发病率呈下降趋势的国家数。
  • 33个国家中男性24个、女性25个国家的皮肤鳞状细胞癌伤残调整寿命年总体减少。

核心结论

  • 过去27年间,尽管大多数国家皮肤鳞状细胞癌发病率上升,但有证据表明死亡率在下降,且多数国家伤残调整寿命年减少。
  • 未来工作将探索观察到的皮肤鳞状细胞癌发病率与死亡率趋势差异的潜在解释因素。

研究设计与样本

  • 基于全球疾病负担数据库的观察性研究,纳入1990至2017年欧盟国家及其他选定的高收入国家(包括英国和美国),共33个国家。
  • 从全球疾病负担数据库获取各国年度年龄标化发病率、年龄标化死亡率及伤残调整寿命年,采用连接点回归分析描述趋势。

主要发现

  • 2015至2017年,基底细胞癌和皮肤鳞状细胞癌年龄标化发病率最高的国家均为美国和澳大利亚。
  • 观察期末,所有国家男性皮肤鳞状细胞癌年龄标化发病率均高于女性;基底细胞癌除两个国家外,其余国家男性年龄标化发病率均高于女性。
  • 皮肤鳞状细胞癌年龄标化死亡率最高者:男性在澳大利亚和拉脱维亚,女性在罗马尼亚和克罗地亚。
  • 两性皮肤鳞状细胞癌伤残调整寿命年最高的国家均为澳大利亚和罗马尼亚。
  • 观察期内,死亡率呈下降趋势的国家数多于发病率呈下降趋势的国家数,且高死亡率国家与高发病率国家之间存在差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Keratinocyte cancers (KCs) are the most common type of cancer in the White population worldwide, with associated high healthcare costs. Understanding the epidemiological trends for KCs, namely basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (SCCs), is required to assess burden of disease, project future trends and identify strategies for addressing this pressing global health issue. OBJECTIVES: To report trends in BCC and SCC incidence, and SCC mortality and disability-adjusted life-years (DALYs). METHODS: An observational study of the Global Burden of Disease (GBD) database between 1990 and 2017 was performed. European Union countries and other selected high-income countries, including the UK and the USA, classified as having high-quality mortality data, were included. Annual age-standardized incidence rates (ASIRs), age-standardized death rates (ASDRs) and DALYs for each country were obtained from the GBD database. Trends were described using joinpoint regression analysis. RESULTS: Overall, 33 countries were included. For both BCC and SCC in 2015-2017, the highest ASIRs were observed in the USA and Australia. Males had higher ASIRs than females at the end of the observation period in all countries for SCC, and in all countries but two for BCC. In contrast, the highest ASDRs for SCC were observed in Australia and Latvia for males, and in Romania and Croatia for females. The highest DALYs for SCC for both sexes were seen in Australia and Romania. Over the observation period, there were more countries demonstrating decreasing trends in mortality than in incidence, and disparities were observed between which countries had comparatively high mortality rates and which had high incidence rates. Overall reductions in SCC DALYs were observed in 24 of 33 countries for males, and 25 countries for females. CONCLUSIONS: Over the past 27 years, although trends in SCC incidence have risen in most countries, there is evidence that mortality rates have been decreasing. Burden of disease as assessed using DALYs has decreased in the majority of countries. Future work will explore potential explanatory factors for the observed disparity in trends in SCC incidence and mortality.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Yang DD, Borsky K, Jani C, et al. Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017. Br J Dermatol. 2023. PMID: 36763862. doi:10.1093/bjd/ljac064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。